MarketCap
Facebook
X
TelegramAnnual report 2025
added 04-15-2026
NanoVibronix Retained Earnings 2011-2026 | NAOV
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings NanoVibronix
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -90.5 M | -69.8 M | -66.1 M | -62.4 M | -56.9 M | - | -38.3 M | -32.5 M | -28.4 M | -22.6 M | -19.7 M | -16.8 M | -14.2 M | -12.2 M | -10.9 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.9 M | -90.5 M | -38.7 M |
Quarterly Retained Earnings NanoVibronix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -76.9 M | -76 M | -72.3 M | -69.8 M | -68.4 M | -67.4 M | -66.7 M | -66.1 M | -65.3 M | -64.6 M | -63.5 M | -62.4 M | -60.3 M | -59.4 M | -58.1 M | -56.9 M | -54.5 M | -47.8 M | -47.6 M | -42.7 M | -42.7 M | -42.7 M | -42.7 M | -38.3 M | -38.3 M | -38.3 M | -38.3 M | -32.5 M | -32.5 M | -32.5 M | -32.5 M | -28.4 M | -28.4 M | -28.4 M | -28.4 M | -22.6 M | -22.6 M | -22.6 M | -22.6 M | -19.7 M | -19.7 M | -19.7 M | -19.7 M | -16.8 M | -16.8 M | -16.8 M | -16.8 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -16.8 M | -76.9 M | -42.7 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 3.28 | - | $ 123 M |  France |
 |
Electromed
ELMD
|
21.2 M | $ 25.74 | - | $ 218 M |  USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 90.74 | - | $ 12.3 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.08 | - | $ 1.26 M | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 13.38 | - | $ 1.81 B | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.23 | - | $ 50 M | USA |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 11.91 | - | $ 472 M |  Curacao |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 182.87 | - | $ 12.9 B | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.6 | -1.96 % | $ 37.3 M | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.15 | - | $ 5.96 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 11.08 | - | $ 314 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Stryker Corporation
SYK
|
20.5 B | $ 321.43 | -0.02 % | $ 123 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Tactile Systems Technology
TCMD
|
54.9 M | $ 23.57 | - | $ 539 M | USA |
 |
TELA Bio
TELA
|
-398 M | $ 0.78 | - | $ 36.6 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 101.26 | - | $ 3.44 B | USA |
 |
Tandem Diabetes Care
TNDM
|
-1.25 B | $ 18.63 | - | $ 1.27 B | USA |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Varex Imaging Corporation
VREX
|
-5.9 M | $ 12.07 | - | $ 500 M | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 5.16 | - | $ 1.09 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Vivos Therapeutics
VVOS
|
-125 M | $ 0.85 | - | $ 8.73 M | USA |
 |
Beyond Air
XAIR
|
-286 M | $ 0.51 | - | $ 34.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 15.14 | - | $ 355 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.55 | - | $ 378 M | USA |
 |
Xtant Medical Holdings
XTNT
|
-254 M | $ 0.55 | -1.78 % | $ 76.7 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
11.1 B | $ 82.8 | - | $ 16.8 B | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.04 | - | $ 17.6 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 36.79 | - | $ 1.14 B | USA |